Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Lymphoma Genomics

Clinical Trials

    • Cancer(6)
  • Lymphoma

    test

    • Pediatric Cancers

      A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

      • Lymphoma

        A Prospective, Observational, Long-term Follow-up Study for Subjects Who Previously Received Zamtocabtagene Autoleucel in a United States Miltenyi Biomedicine-Sponsored Clinical Study

        • Phase 1 Cancers

          First-In-Human, Open-Label, Dose Escalation Trial With Expansion Cohorts to Evaluate the Safety and Preliminary Efficacy of GEN1055 as Monotherapy and as Combination Therapy in Subjects With Malignant Solid Tumors

          • Lymphoma

            Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma

            • Leukemia

              Phase II Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma

              • About Us
              • Contact Us
              • Donate
              • Referring Doctors
              • Clinical Keywords

              333 Cedar St.

              New Haven, CT 06510

              • Yale School of Medicine
              • Yale University
              • Terms & Privacy Policies
              • Accessibility at YSM
              • Patient Rights
              • HIPAA at Yale
              • Non-discrimination Statement
              Copyright 2025 Yale Medicine